Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome

被引:47
作者
Vogelsang, Petra [1 ]
Brun, Johan G. [2 ,3 ]
Oijordsbakken, Gunnvor [4 ]
Skarstein, Kathrine [4 ]
Jonsson, Roland [1 ,2 ]
Appel, Silke [1 ]
机构
[1] Univ Bergen, Broegelmann Res Lab, Gade Inst, N-5021 Bergen, Norway
[2] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway
[3] Univ Bergen, Inst Med, Rheumatol Sect, N-5021 Bergen, Norway
[4] Univ Bergen, Sect Pathol, Gade Inst, N-5021 Bergen, Norway
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; I INTERFERON ACTIVITY; ACTIVATION; IFN; ALPHA;
D O I
10.1136/ard.2009.118158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Sjogren's syndrome (SS) is a lymphoproliferative autoimmune disease, characterised by dryness of the mouth and eyes. Dendritic cells (DC) are potent antigen-presenting cells crucial for initiating and maintaining primary immune responses. This study quantified interferon-producing plasmacytoid DC (pDC) and two myeloid DC subsets (mDC1 and mDC2) in peripheral blood (PB) from primary SS (pSS) patients and healthy controls. Methods Blood samples from 31 pSS patients and 28 gender and age-matched healthy controls were analysed by flow cytometry using the Miltenyi Blood DC enumeration kit. The presence of pDC in salivary glands (SG) from pSS patients was analysed by immunohistochemistry. Results Patients with pSS had significantly less pDC and mDC2 in PB compared with healthy controls. Moreover, pDC are present in SG from patients with pSS. Conclusion Patients with pSS have alterations among DC populations in PB, and pDC are present in the SG, suggesting a potential role of these cells in SS.
引用
收藏
页码:1235 / 1238
页数:4
相关论文
共 20 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   Activation of the type I interferon system in primary Sjogren's syndrome -: A possible etiopathogenic mechanism [J].
Båve, U ;
Nordmark, G ;
Lövgren, T ;
Rönnelid, J ;
Cajander, S ;
Eloranta, ML ;
Alm, GV ;
Rönnblom, L .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1185-1195
[3]   Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus [J].
Blanco, P ;
Palucka, AK ;
Gill, M ;
Pascual, V ;
Banchereau, J .
SCIENCE, 2001, 294 (5546) :1540-1543
[4]   Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood [J].
Chen, Xueqin ;
Makala, Levi H. C. ;
Jin, Yulan ;
Hopkins, Diane ;
Muir, Andy ;
Garge, Nikhil ;
Podolsky, Robert H. ;
She, Jin-Xiong .
CLINICAL IMMUNOLOGY, 2008, 129 (03) :413-418
[5]   Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history [J].
Fitzgerald-Bocarsly, Patricia ;
Dai, Jihong ;
Singh, Sukhwinder .
CYTOKINE & GROWTH FACTOR REVIEWS, 2008, 19 (01) :3-19
[6]   Blood dendritic cells and DC-Poietins in systemic lupus erythematosus [J].
Gill, MA ;
Blanco, P ;
Arce, E ;
Pascual, V ;
Banchereau, J ;
Palucka, AK .
HUMAN IMMUNOLOGY, 2002, 63 (12) :1172-1180
[7]   Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome [J].
Gottenberg, JE ;
Cagnard, N ;
Lucchesi, C ;
Letourneur, F ;
Mistou, S ;
Lazure, T ;
Jacques, S ;
Ba, N ;
Ittah, M ;
Lepajolec, C ;
Labetoulle, M ;
Ardizzone, M ;
Sibilia, J ;
Fournier, C ;
Chiocchia, G ;
Mariette, X .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (08) :2770-2775
[8]   Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis [J].
Jongbloed, SL ;
Lebre, MC ;
Fraser, AR ;
Gracie, JA ;
Sturrock, RD ;
Tak, PP ;
McInnes, IB .
ARTHRITIS RESEARCH & THERAPY, 2006, 8 (01)
[9]   Sjogren's syndrome - A plethora of clinical and immunological phenotypes with a complex genetic background [J].
Jonsson, Roland ;
Bolstad, Anne Isine ;
Brokstad, Karl A. ;
Brun, Johan G. .
AUTOIMMUNITY, PT D: AUTOIMMUNE DISEASE, ANNUS MIRABILIS, 2007, 1108 :433-447
[10]   Augmented interferon-α pathway activation in patients with Sjogren's syndrome treated with etanercept [J].
Mavragani, Clio P. ;
Niewold, Timothy B. ;
Moutsopoulos, Niki M. ;
Pillemer, Stanley R. ;
Wahl, Sharon M. ;
Crow, Mary K. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (12) :3995-4004